Stock listing

Stuttgart:IUI1 Intuitive Surgical, Inc. Aktie

German listing (Stuttgart) of Intuitive Surgical, Inc. · home listing NASDAQ:ISRG

Follow Intuitive Surgical, Inc. into a list and get an email when it puts out news.

Share price · SWB:IUI1

€416.55 EUR -13.05 (-3.0%)

Close on Nov 5, 2026

Past year -12.9% · daily closes, Nov 5, 2025 – Nov 5, 2026, adjusted for splits
Day range
€410.60 – €431.30 EURNov 5, 2026
Volume
57 sharesNov 5, 2026
52-week range
€289.50 – €515.40 EURLowest and highest trades, Nov 6, 2025 – Nov 5, 2026
Traded on an average day
€50,707 EURMedian day 82 shares · 6 days with no trades · last 3 months, Aug 5, 2026 – Nov 5, 2026
Intuitive Surgical, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:ISRG · Home$399.05 USD-21.90 (-5.2%)2,691,938$407.24$410.01$397.78$420.95Close on Nov 20, 2026
TSX:ISRG$20.63 CAD-0.38 (-1.8%)25,334$20.91$21.15$20.53$21.01Close on Nov 20, 2026
Xetra:IUI1€370.15 EUR-10.35 (-2.7%)649€372.10€373.90€369.70€380.50Close on Nov 20, 2026
Cboe Canada:ISRG$20.60 CAD-0.35 (-1.7%)2,339$21.06$21.06$20.60$20.95Close on Nov 20, 2026
Frankfurt:IUI1€365.05 EUR-15.20 (-4.0%)122€368.75€372.60€365.05€380.25Close on Nov 20, 2026
B3:I1SR34124.62 BRL+0.29 (+0.2%)129125.10125.10124.52124.33Close on Nov 19, 2026
Stuttgart:IUI1€416.55 EUR-13.05 (-3.0%)57€428.20€431.30€410.60€429.60Close on Nov 5, 2026
LSE:0R29$405.33 USD-2.24 (-0.5%)2,899$405.70$412.79$402.22$407.57Close on Nov 20, 2026
Munich:IUI1€373.15 EUR-14.80 (-3.8%)5€371.30€373.15€371.30€387.95Close on Nov 20, 2026
Hamburg:IUI1€369.80 EUR-9.60 (-2.5%)22€369.00€370.05€369.00€379.40Close on Nov 20, 2026
Dusseldorf:IUI1€370.10 EUR-4.60 (-1.2%)—€368.60€370.10€368.60€374.70Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 5, 2026 – Nov 5, 2026 · SWB:IUI1 · EUR, adjusted for splits

DayCloseChange%OpenHighLowVolume
€416.55-13.05-3.0%€428.20€431.30€410.6057
€429.60+36.55+9.3%€388.25€432.00€388.25180
€393.05+2.55+0.7%€386.70€395.95€386.70168
€390.50+4.20+1.1%€384.70€398.55€383.350
€386.30-16.55-4.1%€400.90€406.05€386.30112
€402.85+5.55+1.4%€400.20€405.35€399.05138
€397.30-2.80-0.7%€400.00€403.70€393.8067
€400.10-3.55-0.9%€402.00€404.10€398.802,628
€403.65-0.30-0.1%€402.95€409.20€400.45134
€403.95+9.00+2.3%€393.20€408.85€391.05152
€394.95+13.35+3.5%€376.65€394.95€375.9043
€381.60-8.00-2.1%€360.10€384.75€357.55344
€389.60+3.15+0.8%€384.40€391.00€384.2593
€386.45+7.10+1.9%€380.05€387.00€378.100
€379.35-2.10-0.6%€379.05€384.70€378.10102
€381.45+5.55+1.5%€373.00€383.00€372.75106
€375.90-0.95-0.3%€375.40€380.90€373.10103
€376.85-6.25-1.6%€384.95€384.95€372.05508
€383.10+4.55+1.2%€378.50€384.15€377.80188
€378.55+7.65+2.1%€368.80€381.20€368.15332
€370.90+0.85+0.2%€368.60€371.45€366.4028
€370.05+10.10+2.8%€358.25€371.30€357.20133
€359.95-2.80-0.8%€351.40€363.35€347.6517
€362.75+14.75+4.2%€351.40€363.20€347.6582
€348.00-8.85-2.5%€355.70€360.15€348.0063
€356.85-3.50-1.0%€360.70€362.30€356.6069
€360.35-3.00-0.8%€362.90€363.35€358.1091
€363.35-1.10-0.3%€362.10€365.70€359.356
€364.45+8.95+2.5%€352.45€365.40€352.4530
€355.50+4.00+1.1%€350.05€355.50€346.201
€351.50+1.85+0.5%€347.60€354.20€347.0590
€349.65-1.60-0.5%€350.55€353.45€347.90111
€351.25-0.40-0.1%€348.60€352.30€347.55107
€351.65+9.50+2.8%€342.05€351.65€342.0584
€342.15+6.45+1.9%€336.40€342.45€332.05100
€335.70+2.55+0.8%€333.95€337.60€329.8515
€333.15+6.60+2.0%€326.05€334.75€325.5553
€326.55-0.55-0.2%€325.05€327.75€319.650
€327.10+9.30+2.9%€316.80€327.10€316.8046
€317.80+19.25+6.4%€312.70€319.00€312.700
€298.55-4.50-1.5%€306.10€306.10€298.5558
€303.05+0.75+0.2%€301.05€306.00€300.0579
€302.30-13.55-4.3%€314.05€314.05€299.1572
€315.85+0.80+0.3%€315.35€317.05€315.056
€315.05-3.45-1.1%€316.50€319.10€313.3535
€318.50-1.65-0.5%€320.65€324.50€315.30109
€320.15+2.30+0.7%€318.05€329.40€318.05121
€317.85-5.15-1.6%€323.15€325.05€316.3510
€323.00+1.95+0.6%€320.05€323.05€315.8549
€321.05+4.65+1.5%€316.60€321.95€316.100
€316.40-0.85-0.3%€316.45€317.50€315.1556
€317.25-0.80-0.3%€319.35€320.40€315.60112
€318.05-3.05-0.9%€320.05€322.65€316.05116
€321.10-4.30-1.3%€323.10€327.30€321.10122
€325.40+4.65+1.4%€321.05€326.65€317.10121
€320.75-21.45-6.3%€339.20€340.60€319.3030
€342.20+2.55+0.8%€336.70€345.90€336.700
€339.65+2.00+0.6%€336.05€344.60€336.05119
€337.65-4.90-1.4%€340.05€341.30€336.8555
€342.55-5.25-1.5%€346.80€346.95€342.5510
€347.80-0.45-0.1%€346.60€349.05€346.0048
€348.25+1.00+0.3%€345.85€351.15€344.5569
€347.25+8.20+2.4%€341.00€347.25€339.05421
€339.05+11.25+3.4%€328.05€339.05€327.70392
€327.80+4.25+1.3%€322.10€328.05€322.10172
€323.55-1.65-0.5%€324.60€329.20€323.10114
€325.20+5.80+1.8%€319.80€325.20€319.0581

Splits

2 splits since 2017 · SWB:IUI1 · every price before a split is adjusted for it

DayRatioWhat
3-for-1Split
3-for-1Split
Ticker
Stuttgart:IUI1
Asset type
Stock
Sector
Health care
Industry
Medical devices & supplies
Exchange
Stuttgart
Currency
EUR

What changed lately

Latest news

All Intuitive Surgical, Inc. news

Intuitive Surgical, Inc. on 6ix

Sector
Health care
Industry
Medical devices & supplies
News releases
26 in the last 12 months · 79 in all · newest Nov 2, 2026 · oldest 2019
Calls
32 calls with a replay · 32 with a transcript · latest Oct 20, 2026
Decks
15 decks · latest Jan 14, 2026

Where Intuitive Surgical, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:ISRG · Home listingNASDAQUnited StatesUSD
gettex:IUI1gettexGermanyEUR
Tradegate:IUI1TradegateGermanyEUR
LS Exchange:888024LS ExchangeGermanyEUR
TSX:ISRGTSXCanadaCAD
Xetra:IUI1XetraGermanyEUR
SET:ISRG01SETThailandTHB
BCBA:ISRGBCBAArgentinaARS
SET:ISRG06SETThailandTHB
Cboe Canada:ISRGCboe CanadaCanadaCAD
Frankfurt:IUI1FrankfurtGermanyEUR
BMV:ISRGBMVMexicoMXN
SET:ISRG19SETThailandTHB
Milan:1ISRGMilanItalyEUR
B3:I1SR34B3BrazilBRL
BOATS:ISRGBOATSUnited StatesUSD
Stuttgart:IUI1 · This pageStuttgartGermanyEUR
Lang & Schwarz:888024Lang & SchwarzGermanyEUR
LSE:0R29LSEUnited KingdomUSD
Frankfurt:IUIFrankfurtGermanyEUR
VIE:ISRGViennaAustriaEUR
EUROTLX:4ISRGEUROTLXItalyEUR
BIVA:ISRGBIVAMexicoMXN
Munich:IUI1MunichGermanyEUR
BX Swiss:IUI1BX SwissSwitzerlandCHF
BCBA:ISRGDBCBAArgentinaUSD
Hamburg:IUI1HamburgGermanyEUR
BCBA:ISRGCBCBAArgentinaUSD
Hanover:IUI1HanoverGermanyEUR
Dusseldorf:IUI1DusseldorfGermanyEUR
Turquoise:ISRGNTurquoiseUnited KingdomUSD
BCBA:ISRG.CIBCBAArgentinaARS
SET:ISRG80SETThailandTHB

Valuation

P/E 46.8× against a median of 26.6×: 8th lowest of 11 Medical devices & supplies companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$134.3B USD
P/E
46.8×
EV/sales
11.6×
EV/EBITDA
No depreciation figure on 6ix yet
Price/book
8.7×
Gross margin
67.2%
Operating margin
28.4%
Net margin
25.5%
Debt to equity
0.0×
Beta vs S&P 500
0.90

Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Intuitive Surgical, Inc. · NASDAQ:ISRGUS$138.3BUS$134.3B46.8×11.6×n/a8.7×25.5%0.0×0.90
Medtronic plc. · NYSE:MDTUS$127.8BUS$144.6B24.4×3.9×14.9×2.5×13.9%0.5×0.15
Stryker Corporation · NYSE:SYKUS$118.0BUS$129.7B32.6×4.9×n/a5.0×13.8%0.6×0.25
Boston Scientific Corporation · NYSE:BSXUS$60.85BUS$71.15B17.4×3.4×n/a2.4×16.6%0.4×0.31
Edwards Lifesciences Corporation · NYSE:EWUS$58.56BUS$54.52B57.3×8.2×33.8×5.4×15.3%0.1×0.54
Becton, Dickinson and Company · NYSE:BDXUS$57.96BUS$70.76B61.6×3.2×14.8×2.4×4.2%0.6×0.29
Siemens Healthineers AG · XETR:SHLUS$52.77BUS$49.52B21.7×1.9×10.3×2.4×9.4%0.0×n/a
GE HealthCare Technologies Inc. · NASDAQ:GEHCUS$36.46BUS$43.61B16.9×2.0×13.7×3.1×10.0%0.9×0.65
Alcon AG · SIX:ALCUS$35.86BUS$38.74B54.0×3.5×16.1×1.6×6.1%0.2×n/a
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Class A · SZSE:300760US$33.43BUS$30.45B28.7×5.9×n/a5.4×22.4%0.0×n/a
ResMed Inc. · NYSE:RMDUS$33.14BUS$32.54B20.8×5.7×15.6×5.6×27.8%0.1×0.48
Median of the othersUS$55.36BUS$52.02B26.6×3.7×14.9×2.8×13.9%0.3×0.31

Forecasts

19 strong buy · 7 buy · 6 hold · 1 sell · 1 strong sell · Analysts' consensus from EODHD, read Nov 16, 2026. Not 6ix's view and not investment advice.

Price target
486.57 USD · Analysts' mean
EPS, year to Dec 2026
11.25 · 27 analysts
Revenue, year to Dec 2026
11.93B · 31 analysts

Team and board

Officers

OfficerRole
Monica P. ReedPresident and CEO of UChicago Medicine Advent Health
Catherine MohrIntuitive Foundation President
Dave RosaPresident
Sreelakshmi KolliExecutive Vice President, Chief Product and Digital Officer
Gary S. GuthartExecutive Chair of the Board of Directors

Board

DirectorRole
Keith R. LeonardChairman, Unity Biotechnology, Inc
Aaron MartinDirector (from Jan 1, 2027)
Craig H. BarrattLead Independent Director, Intuitive

Events

Calls

CallWhenStatus
Intuitive Surgical (NASDAQ:ISRG) Q3 2026 Earnings CallTue, Oct 20, 2026 · 4:30 PM ETReplay
Intuitive Surgical (NASDAQ:ISRG) Q2 2026 Earnings CallThu, Jul 16, 2026 · 4:30 PM ETReplay
Intuitive Surgical (NASDAQ:ISRG) Q1 2026 Earnings CallTue, Apr 21, 2026 · 4:30 PM ETReplay
Intuitive Surgical (NASDAQ:ISRG) Q4 2025 Earnings CallThu, Jan 22, 2026 · 4:00 PM ETReplay
Intuitive Surgical (NASDAQ:ISRG) Q3 2025 Earnings CallTue, Oct 21, 2025 · 4:30 PM ETReplay
Intuitive Surgical (NASDAQ:ISRG) Q2 2025 Earnings CallTue, Jul 22, 2025 · 4:30 PM ETReplay
Intuitive Surgical (NASDAQ:ISRG) Q1 2025 Earnings CallTue, Apr 22, 2025 · 4:30 PM ETReplay
Intuitive Surgical (NASDAQ:ISRG) Q4 2024 Earnings CallThu, Jan 23, 2025 · 4:30 PM ETReplay
Intuitive Surgical (NASDAQ:ISRG) Q3 2024 Earnings CallThu, Oct 17, 2024 · 4:30 PM ETReplay
Intuitive Surgical (NASDAQ:ISRG) Q2 2024 Earnings CallThu, Jul 18, 2024 · 4:30 PM ETReplay
All 32 calls
CallWhenStatus
Intuitive Surgical (NASDAQ:ISRG) Q1 2024 Earnings CallThu, Apr 18, 2024 · 4:30 PM ETReplay
Intuitive Surgical (NASDAQ:ISRG) Q4 2023 Earnings CallTue, Jan 23, 2024 · 1:30 PM ETReplay
Intuitive Surgical (NASDAQ:ISRG) Q3 2023 Earnings CallThu, Oct 19, 2023 · 4:30 PM ETReplay
Intuitive Surgical (NASDAQ:ISRG) Q2 2023 Earnings CallThu, Jul 20, 2023 · 4:30 PM ETReplay
Intuitive Surgical (NASDAQ:ISRG) Q1 2023 Earnings CallTue, Apr 18, 2023 · 4:30 PM ETReplay
Intuitive Surgical (NASDAQ:ISRG) Q4 2022 Earnings CallTue, Jan 24, 2023 · 4:30 PM ETReplay
Intuitive Surgical (NASDAQ:ISRG) Q3 2022 Earnings CallTue, Oct 18, 2022 · 4:30 PM ETReplay
Intuitive Surgical (NASDAQ:ISRG) Q2 2022 Earnings CallThu, Jul 21, 2022 · 4:30 PM ETReplay
Intuitive Surgical (NASDAQ:ISRG) Q1 2022 Earnings CallThu, Apr 21, 2022 · 4:30 PM ETReplay
Intuitive Surgical (NASDAQ:ISRG) Q4 2021 Earnings CallThu, Jan 20, 2022 · 4:30 PM ETReplay
Intuitive Surgical (NASDAQ:ISRG) Q3 2021 Earnings CallTue, Oct 19, 2021 · 4:30 PM ETReplay
Intuitive Surgical (NASDAQ:ISRG) Q2 2021 Earnings CallTue, Jul 20, 2021 · 4:30 PM ETReplay
Intuitive Surgical (NASDAQ:ISRG) Q1 2021 Earnings CallTue, Apr 20, 2021 · 1:30 PM ETReplay
Intuitive Surgical (NASDAQ:ISRG) Q4 2020 Earnings CallThu, Jan 21, 2021 · 4:30 PM ETReplay
Intuitive Surgical (NASDAQ:ISRG) Q3 2020 Earnings CallThu, Oct 15, 2020 · 4:30 PM ETReplay
Intuitive Surgical (NASDAQ:ISRG) Q2 2020 Earnings CallTue, Jul 21, 2020 · 4:30 PM ETReplay
Intuitive Surgical (NASDAQ:ISRG) Q1 2020 Earnings CallThu, Apr 16, 2020 · 4:30 PM ETReplay
Intuitive Surgical (NASDAQ:ISRG) Q4 2019 Earnings CallThu, Jan 23, 2020 · 4:30 PM ETReplay
Intuitive Surgical (NASDAQ:ISRG) Q3 2019 Earnings CallThu, Oct 17, 2019 · 4:30 PM ETReplay
Intuitive Surgical (NASDAQ:ISRG) Q2 2019 Earnings CallThu, Jul 18, 2019 · 4:30 PM ETReplay
Intuitive Surgical (NASDAQ:ISRG) Q1 2019 Earnings CallThu, Apr 18, 2019 · 4:30 PM ETReplay
Intuitive Surgical (NASDAQ:ISRG) Q4 2018 Earnings CallThu, Jan 24, 2019 · 4:30 PM ETReplay

Results days

QuarterResultsShare move
Q3 2026Oct 20, 2026 · After close−2.3%
Q2 2026Jul 16, 2026 · After close−14.2%
Q1 2026Apr 21, 2026 · After close+7.2%
Q4 2025Jan 22, 2026 · After close−0.3%
Q3 2025Oct 21, 2025 · After close+13.9%
Q2 2025Jul 22, 2025 · After close−1.8%
Q1 2025Apr 22, 2025 · After close+1.9%
Q4 2024Jan 23, 2025 · After close−4.0%
Q3 2024Oct 17, 2024 · After close+10.0%
Q2 2024Jul 18, 2024 · After close+9.3%
All 20 quarters
QuarterResultsShare move
Q1 2024Apr 18, 2024 · After close−1.7%
Q4 2023Jan 23, 2024 · After close−0.4%
Q3 2023Oct 19, 2023 · After close−2.4%
Q2 2023Jul 20, 2023 · After close−3.2%
Q1 2023Apr 18, 2023 · After close+10.9%
Q4 2022Jan 24, 2023 · After close−5.5%
Q3 2022Oct 18, 2022 · After close+9.0%
Q2 2022Jul 21, 2022 · After close−5.7%
Q1 2022Apr 21, 2022 · After close−14.3%
Q4 2021Jan 20, 2022 · After close−7.9%

Open Events

Decks

DeckKindSlidesDate
J.P. Morgan Healthcare Conference 2026Conference27 slidesJan 14, 2026
Q3 2026 Earnings PresentationEarnings19 slides2026
Q2 2026 Earnings PresentationEarnings19 slides2026
Q1 2025 Earnings PresentationEarnings27 slidesApr 22, 2025
Q3 2024 Earnings PresentationEarnings27 slidesOct 17, 2024
Q2 2024 Earnings PresentationEarnings27 slidesJul 18, 2024
Investor Presentation (June 2024)Investor deck4 slidesJune 2024
Q1 2024 Earnings PresentationEarnings27 slidesApr 18, 2024
Q3 2023 Earnings PresentationEarnings21 slidesOct 19, 2023
Q2 2023 Earnings PresentationEarnings21 slidesJul 20, 2023
All 15 decks
DeckKindSlidesDate
Q1 2023 Earnings PresentationEarnings21 slidesApr 18, 2023
Investor Presentation (March 2023)Investor deck11 slidesMarch 2023
Investor Presentation (December 2018)Investor deck43 slidesDecember 2018
Investor Presentation (August 2018)Investor deck14 slidesAugust 2018
Fact SheetFact sheet1 slide

Open Decks

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue10.1B8.35B7.12B6.22B5.71B4.36B4.48B3.72B3.14B2.71B
Cost of revenue3.42B2.72B2.39B2.03B1.75B1.50B1.37B1.12B934.8M814.3M
Gross profit6.64B5.63B4.73B4.20B3.96B2.86B3.11B2.60B2.20B1.89B
Research and development1.31B1.15B998.8M879.0M671.0M595.1M557.3M418.1M328.6M239.6M
Selling, general and administrative2.38B2.14B1.96B1.74B1.47B1.22B1.18B986.6M810.5M703.6M
Operating income2.95B2.35B1.77B1.58B1.82B1.05B1.37B1.20B1.06B949.7M
Depreciation and amortization600.0M439.0M382.0M326.0M280.0M221.0M157.0M105.9M82.1M70.7M
EBITDA3.55B2.79B2.15B1.90B2.10B1.27B1.53B1.31B1.15B1.02B
Income before tax3.31B2.67B1.96B1.61B1.89B1.21B1.50B1.28B1.10B985.3M
Income tax434.8M336.3M141.6M262.4M162.2M140.2M120.4M154.5M433.9M247.0M
Net income2.86B2.32B1.80B1.32B1.70B1.06B1.38B1.13B670.9M738.3M
Earnings per share, basic8.006.545.123.724.793.023.989.926.016.43
Earnings per share, diluted7.876.425.033.654.662.943.859.495.776.26

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents3.37B2.03B2.75B1.58B1.29B1.62B1.17B857.9M648.2M1.04B
Short-term investments2.57B1.99B2.47B2.54B2.91B3.49B2.05B2.21B1.31B1.52B
Receivables1.53B1.23B1.13B942.1M782.7M645.5M645.2M682.3M507.9M430.2M
Inventory1.84B1.49B1.22B893.2M587.1M601.5M595.5M409.0M241.2M182.3M
Current assets9.78B7.11B7.89B6.25B5.84B6.63B4.66B4.33B2.81B3.25B
Property, plant and equipment5.34B4.65B3.54B2.37B1.88B1.58B1.27B812.0M613.1M458.4M
Goodwill370.3M347.5M348.7M348.5M343.6M336.7M307.2M240.6M201.1M201.1M
Total assets20.5B18.7B15.4B13.0B13.6B11.2B9.73B7.85B5.78B6.49B
Accounts payable255.1M193.4M188.7M147.0M121.2M81.6M123.5M100.7M82.5M68.5M
Current liabilities2.01B1.75B1.66B1.42B1.15B965.2M1.03B820.6M662.8M596.5M
Total liabilities2.52B2.21B2.04B1.86B1.60B1.41B1.45B1.16B996.4M709.1M
Shareholders' equity17.8B16.4B13.3B11.0B11.9B9.73B8.26B6.68B4.78B5.78B
Shares outstanding355.1M356.6M352.3M350.0M357.7M353.1M116.0M114.5M112.3M116.4M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations3.03B2.42B1.81B1.49B2.09B1.48B1.60B1.17B1.14B1.09B
Capital spending-539.8M-1.11B-1.06B-532.4M-339.5M-341.5M-425.6M-187.4M-190.7M-53.9M
Free cash flow2.49B1.30B749.6M958.4M1.75B1.14B1.17B982.2M953.2M1.03B
Cash from investing665.8M-3.27B-360.1M1.37B-2.46B-940.6M-1.15B-1.05B378.7M-1.28B
Cash from financing-2.36B150.9M-287.6M-2.57B43.0M-85.7M-168.4M126.3M-1.91B514.4M
Share buybacks-2.30B0-416.3M-2.61B0-134.3M-269.5M0-2.27B-42.5M
Change in cash1.34B-707.7M1.17B294.7M-332.5M455.9M273.2M246.2M-388.4M322.0M

Open Financials

Filings

FilingDateTypeFiled with
4 · Change in ownershipNov 20, 2026Insider tradeSEC
S-8 · Registration statement for employee plansNov 19, 2026Offer documentSEC
4 · Change in ownershipNov 18, 2026Insider tradeSEC
4 · Change in ownershipNov 12, 2026Insider tradeSEC
144 · Notice of proposed saleNov 10, 2026Other filingsSEC
4 · Change in ownershipNov 5, 2026Insider tradeSEC
4 · Change in ownershipNov 5, 2026Insider tradeSEC
144 · Notice of proposed saleNov 4, 2026Other filingsSEC
8-K · Current reportNov 2, 2026Management or board changeSEC
4 · Change in ownershipNov 2, 2026Insider tradeSEC
Show 200 filings
FilingDateTypeFiled with
4 · Change in ownershipNov 2, 2026Insider tradeSEC
144 · Notice of proposed saleOct 30, 2026Other filingsSEC
4 · Change in ownershipOct 28, 2026Insider tradeSEC
4 · Change in ownershipOct 26, 2026Insider tradeSEC
4 · Change in ownershipOct 26, 2026Insider tradeSEC
4 · Change in ownershipOct 26, 2026Insider tradeSEC
4 · Change in ownershipOct 26, 2026Insider tradeSEC
144 · Notice of proposed saleOct 23, 2026Other filingsSEC
144 · Notice of proposed saleOct 23, 2026Other filingsSEC
144 · Notice of proposed saleOct 23, 2026Other filingsSEC
144 · Notice of proposed saleOct 23, 2026Other filingsSEC
10-Q · Quarterly reportOct 21, 2026Quarterly reportSEC
8-K · Current reportOct 20, 2026ResultsSEC
4 · Change in ownershipOct 13, 2026Insider tradeSEC
4 · Change in ownershipOct 13, 2026Insider tradeSEC
4 · Change in ownershipSep 16, 2026Insider tradeSEC
144 · Notice of proposed saleSep 15, 2026Other filingsSEC
4 · Change in ownershipSep 11, 2026Insider tradeSEC
4 · Change in ownershipSep 9, 2026Insider tradeSEC
144 · Notice of proposed saleSep 8, 2026Other filingsSEC
4 · Change in ownershipAug 21, 2026Insider tradeSEC
4 · Change in ownershipAug 19, 2026Insider tradeSEC
4 · Change in ownershipAug 12, 2026Insider tradeSEC
4 · Change in ownershipAug 11, 2026Insider tradeSEC
144 · Notice of proposed saleAug 11, 2026Other filingsSEC
4 · Change in ownershipAug 10, 2026Insider tradeSEC
144 · Notice of proposed saleAug 10, 2026Other filingsSEC
144 · Notice of proposed saleAug 10, 2026Other filingsSEC
4 · Change in ownershipJul 31, 2026Insider tradeSEC
4 · Change in ownershipJul 29, 2026Insider tradeSEC
8-K · Current reportJul 27, 2026Current reportSEC
S-8 · Registration statement for employee plansJul 21, 2026Offer documentSEC
10-Q · Quarterly reportJul 21, 2026Quarterly reportSEC
8-K · Current reportJul 16, 2026ResultsSEC
4 · Change in ownershipJul 13, 2026Insider tradeSEC
4 · Change in ownershipJun 12, 2026Insider tradeSEC
4 · Change in ownershipJun 10, 2026Insider tradeSEC
4 · Change in ownershipJun 10, 2026Insider tradeSEC
144 · Notice of proposed saleJun 10, 2026Other filingsSEC
4 · Change in ownershipJun 10, 2026Insider tradeSEC
144 · Notice of proposed saleJun 8, 2026Other filingsSEC
144 · Notice of proposed saleJun 3, 2026Other filingsSEC
4 · Change in ownershipJun 2, 2026Insider tradeSEC
144 · Notice of proposed saleJun 1, 2026Other filingsSEC
8-K · Current reportMay 28, 2026Management or board changeSEC
4 · Change in ownershipMay 22, 2026Insider tradeSEC
SD · Specialized disclosureMay 21, 2026ESG reportSEC
4 · Change in ownershipMay 20, 2026Insider tradeSEC
4 · Change in ownershipMay 11, 2026Insider tradeSEC
144 · Notice of proposed saleMay 11, 2026Other filingsSEC
8-K · Current reportMay 4, 2026Management or board changeSEC
4 · Change in ownershipMay 1, 2026Insider tradeSEC
4 · Change in ownershipApr 30, 2026Insider tradeSEC
4 · Change in ownershipApr 30, 2026Insider tradeSEC
4 · Change in ownershipApr 30, 2026Insider tradeSEC
4 · Change in ownershipApr 30, 2026Insider tradeSEC
4 · Change in ownershipApr 30, 2026Insider tradeSEC
4 · Change in ownershipApr 30, 2026Insider tradeSEC
4 · Change in ownershipApr 30, 2026Insider tradeSEC
4 · Change in ownershipApr 30, 2026Insider tradeSEC
4 · Change in ownershipApr 30, 2026Insider tradeSEC
SCHEDULE 13G · Big-stake noticeApr 30, 2026Big-stake noticeSEC
4 · Change in ownershipApr 29, 2026Insider tradeSEC
144 · Notice of proposed saleApr 28, 2026Other filingsSEC
144 · Notice of proposed saleApr 27, 2026Other filingsSEC
10-Q · Quarterly reportApr 22, 2026Quarterly reportSEC
8-K · Current reportApr 21, 2026ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedMar 27, 2026Big-stake noticeSEC
DEFA14A · Additional proxy materialMar 13, 2026Meeting noticeSEC
ARS · Annual report to shareholdersMar 13, 2026Annual reportSEC
DEF 14A · Proxy statementMar 13, 2026Meeting noticeSEC
4 · Change in ownershipMar 11, 2026Insider tradeSEC
144 · Notice of proposed saleMar 10, 2026Other filingsSEC
4 · Change in ownershipMar 10, 2026Insider tradeSEC
4 · Change in ownershipMar 5, 2026Insider tradeSEC
144 · Notice of proposed saleMar 5, 2026Other filingsSEC
144 · Notice of proposed saleMar 4, 2026Other filingsSEC
4 · Change in ownershipMar 3, 2026Insider tradeSEC
4 · Change in ownershipMar 3, 2026Insider tradeSEC
144 · Notice of proposed saleMar 3, 2026Other filingsSEC
144 · Notice of proposed saleMar 3, 2026Other filingsSEC
144 · Notice of proposed saleMar 3, 2026Other filingsSEC
4 · Change in ownershipMar 3, 2026Insider tradeSEC
4 · Change in ownershipMar 3, 2026Insider tradeSEC
4 · Change in ownershipMar 2, 2026Insider tradeSEC
4 · Change in ownershipMar 2, 2026Insider tradeSEC
4 · Change in ownershipMar 2, 2026Insider tradeSEC
8-K · Current reportMar 2, 2026Current reportSEC
4 · Change in ownershipMar 2, 2026Insider tradeSEC
4 · Change in ownershipMar 2, 2026Insider tradeSEC
144 · Notice of proposed saleMar 2, 2026Other filingsSEC
4 · Change in ownershipMar 2, 2026Insider tradeSEC
4 · Change in ownershipFeb 27, 2026Insider tradeSEC
144 · Notice of proposed saleFeb 27, 2026Other filingsSEC
144 · Notice of proposed saleFeb 27, 2026Other filingsSEC
144 · Notice of proposed saleFeb 27, 2026Other filingsSEC
4 · Change in ownershipFeb 27, 2026Insider tradeSEC
4 · Change in ownershipFeb 27, 2026Insider tradeSEC
4 · Change in ownershipFeb 27, 2026Insider tradeSEC
4 · Change in ownershipFeb 27, 2026Insider tradeSEC
4 · Change in ownershipFeb 27, 2026Insider tradeSEC
4 · Change in ownershipFeb 27, 2026Insider tradeSEC
4 · Change in ownershipFeb 27, 2026Insider tradeSEC
4 · Change in ownershipFeb 27, 2026Insider tradeSEC
4 · Change in ownershipFeb 27, 2026Insider tradeSEC
144 · Notice of proposed saleFeb 18, 2026Other filingsSEC
4 · Change in ownershipFeb 11, 2026Insider tradeSEC
4 · Change in ownershipFeb 11, 2026Insider tradeSEC
144 · Notice of proposed saleFeb 11, 2026Other filingsSEC
144 · Notice of proposed saleFeb 11, 2026Other filingsSEC
4 · Change in ownershipFeb 10, 2026Insider tradeSEC
4 · Change in ownershipFeb 10, 2026Insider tradeSEC
144 · Notice of proposed saleFeb 10, 2026Other filingsSEC
4 · Change in ownershipFeb 10, 2026Insider tradeSEC
4 · Change in ownershipFeb 10, 2026Insider tradeSEC
4 · Change in ownershipFeb 10, 2026Insider tradeSEC
4 · Change in ownershipFeb 10, 2026Insider tradeSEC
4 · Change in ownershipFeb 10, 2026Insider tradeSEC
3 · Initial statement of ownershipFeb 5, 2026Insider tradeSEC
3 · Initial statement of ownershipFeb 5, 2026Insider tradeSEC
10-K · Annual reportFeb 3, 2026Annual reportSEC
4 · Change in ownershipJan 30, 2026Insider tradeSEC
4 · Change in ownershipJan 30, 2026Insider tradeSEC
4 · Change in ownershipJan 30, 2026Insider tradeSEC
4 · Change in ownershipJan 30, 2026Insider tradeSEC
4 · Change in ownershipJan 30, 2026Insider tradeSEC
4 · Change in ownershipJan 30, 2026Insider tradeSEC
4 · Change in ownershipJan 30, 2026Insider tradeSEC
4 · Change in ownershipJan 30, 2026Insider tradeSEC
144 · Notice of proposed saleJan 29, 2026Other filingsSEC
4 · Change in ownershipJan 28, 2026Insider tradeSEC
4 · Change in ownershipJan 28, 2026Insider tradeSEC
144 · Notice of proposed saleJan 27, 2026Other filingsSEC
144 · Notice of proposed saleJan 27, 2026Other filingsSEC
144 · Notice of proposed saleJan 27, 2026Other filingsSEC
8-K · Current reportJan 22, 2026ResultsSEC
8-K · Current reportJan 14, 2026ResultsSEC
8-K · Current reportDec 18, 2025Management or board changeSEC
4 · Change in ownershipDec 17, 2025Insider tradeSEC
4/A · Change in ownership, amendedDec 17, 2025Insider tradeSEC
4 · Change in ownershipDec 15, 2025Insider tradeSEC
144 · Notice of proposed saleDec 12, 2025Other filingsSEC
4 · Change in ownershipDec 10, 2025Insider tradeSEC
144 · Notice of proposed saleDec 10, 2025Other filingsSEC
4 · Change in ownershipDec 2, 2025Insider tradeSEC
4 · Change in ownershipDec 2, 2025Insider tradeSEC
144 · Notice of proposed saleDec 1, 2025Other filingsSEC
144 · Notice of proposed saleDec 1, 2025Other filingsSEC
4 · Change in ownershipNov 13, 2025Insider tradeSEC
4 · Change in ownershipNov 13, 2025Insider tradeSEC
4 · Change in ownershipNov 13, 2025Insider tradeSEC
144 · Notice of proposed saleNov 12, 2025Other filingsSEC
144 · Notice of proposed saleNov 12, 2025Other filingsSEC
4 · Change in ownershipNov 12, 2025Insider tradeSEC
4 · Change in ownershipNov 12, 2025Insider tradeSEC
144 · Notice of proposed saleNov 10, 2025Other filingsSEC
144 · Notice of proposed saleNov 10, 2025Other filingsSEC
4 · Change in ownershipNov 6, 2025Insider tradeSEC
144 · Notice of proposed saleNov 5, 2025Other filingsSEC
4 · Change in ownershipNov 3, 2025Insider tradeSEC
4 · Change in ownershipOct 29, 2025Insider tradeSEC
144 · Notice of proposed saleOct 29, 2025Other filingsSEC
144 · Notice of proposed saleOct 28, 2025Other filingsSEC
4 · Change in ownershipOct 27, 2025Insider tradeSEC
4 · Change in ownershipOct 27, 2025Insider tradeSEC
4 · Change in ownershipOct 27, 2025Insider tradeSEC
144 · Notice of proposed saleOct 24, 2025Other filingsSEC
144 · Notice of proposed saleOct 24, 2025Other filingsSEC
144 · Notice of proposed saleOct 24, 2025Other filingsSEC
10-Q · Quarterly reportOct 22, 2025Quarterly reportSEC
8-K · Current reportOct 21, 2025ResultsSEC
4 · Change in ownershipOct 10, 2025Insider tradeSEC
4 · Change in ownershipSep 4, 2025Insider tradeSEC
144 · Notice of proposed saleSep 4, 2025Other filingsSEC
144 · Notice of proposed saleSep 3, 2025Other filingsSEC
4 · Change in ownershipSep 2, 2025Insider tradeSEC
144 · Notice of proposed saleAug 29, 2025Other filingsSEC
4 · Change in ownershipJul 29, 2025Insider tradeSEC
144 · Notice of proposed saleJul 28, 2025Other filingsSEC
144 · Notice of proposed saleJul 28, 2025Other filingsSEC
4 · Change in ownershipJul 25, 2025Insider tradeSEC
144 · Notice of proposed saleJul 25, 2025Other filingsSEC
S-8 · Registration statement for employee plansJul 23, 2025Offer documentSEC
10-Q · Quarterly reportJul 23, 2025Quarterly reportSEC
8-K · Current reportJul 22, 2025ResultsSEC
4 · Change in ownershipJul 11, 2025Insider tradeSEC
144 · Notice of proposed saleJun 10, 2025Other filingsSEC
4 · Change in ownershipJun 10, 2025Insider tradeSEC
4 · Change in ownershipJun 6, 2025Insider tradeSEC
144 · Notice of proposed saleJun 6, 2025Other filingsSEC

This page holds 200 of 1,000 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Intuitive Surgical, Inc.’s releases · as of Oct 15, 2026

Common shares
346,643,718
Fully diluted
346,643,718

Fully diluted

LineSharesAs of
Common shares346,643,718Oct 15, 2026

Share count over time

CountShares
Oct 15, 2026346,643,718

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueAs of
Vanguard34.4M9.9%US$14BSep 30, 2026
BlackRock29.6M8.5%US$12BSep 30, 2026
State Street16.2M4.7%US$6.58BSep 30, 2026
Invesco12M3.5%US$4.89BSep 30, 2026
Capital Group10.9M3.1%US$4.42BSep 30, 2026
T. Rowe Price10M2.9%US$4.07BSep 30, 2026
Geode Capital8.54M2.5%US$3.46BSep 30, 2026
Morgan Stanley7.75M2.2%US$3.15BSep 30, 2026
UBS6.15M1.8%US$2.5BSep 30, 2026
JPMorgan4.75M1.4%US$1.96BSep 30, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
Arrowstreet Capital, Limited Partnership4.19M1.2%US$1.7BSep 30, 2026
Fisher Asset Management, LLC3.88M1.1%US$1.58BSep 30, 2026
Northern Trust3.52M1.0%US$1.43BSep 30, 2026
BNY3.5M1.0%US$1.42BSep 30, 2026
Jennison Associates LLC3.45M1.00%US$1.4BSep 30, 2026
Wellington3.35M0.97%US$1.36BSep 30, 2026
AllianceBernstein3.25M0.94%US$1.32BSep 30, 2026
Amundi2.99M0.86%US$1.22BSep 30, 2026
Franklin Templeton2.97M0.86%US$1.34BSep 30, 2026
Bank of America2.86M0.83%US$1.16BSep 30, 2026
Schwab2.57M0.74%US$1.05BSep 30, 2026
Legal & General2.49M0.72%US$1.01BSep 30, 2026
Baillie Gifford & Co2.48M0.71%US$1.01BSep 30, 2026
Fidelity2.31M0.67%US$939MSep 30, 2026
Goldman Sachs2.21M0.64%US$900MSep 30, 2026
Janus Henderson2.15M0.62%US$874MSep 30, 2026
BNP Paribas1.92M0.56%US$782MSep 30, 2026
Nuveen1.91M0.55%US$775MSep 30, 2026
Sumitomo Mitsui Trust Group, Inc.1.89M0.55%US$770MSep 30, 2026
DWS1.75M0.51%US$713MSep 30, 2026
RBC1.7M0.49%US$691MSep 30, 2026
Loomis Sayles & Co L P1.67M0.48%US$679MSep 30, 2026
Assenagon Asset Management S.A.1.56M0.45%US$634MSep 30, 2026
MUFG1.44M0.42%US$587MSep 30, 2026
American Century1.43M0.41%US$582MSep 30, 2026
Citadel1.37M0.40%US$557MSep 30, 2026
Pictet Asset Management Holding SA1.3M0.38%US$530MSep 30, 2026
Victory Capital1.26M0.36%US$514MSep 30, 2026
Grantham, Mayo, Van Otterloo & Co. LLC1.25M0.36%US$508MSep 30, 2026
AQR Capital Management LLC1.24M0.36%US$505MSep 30, 2026
Barclays1.21M0.35%US$493MSep 30, 2026
Brown Advisory Inc1.13M0.33%US$461MSep 30, 2026
Sands Capital Management, LLC1.13M0.33%US$461MSep 30, 2026
Lazard Asset Management LLC1.09M0.31%US$443MSep 30, 2026
Wells Fargo1.03M0.30%US$419MSep 30, 2026
Ameriprise1.02M0.29%US$416MSep 30, 2026
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.982K0.28%US$399MSep 30, 2026
Swiss National Bank969K0.28%US$394MSep 30, 2026
California Public Employees Retirement System871K0.25%US$354MSep 30, 2026
Nomura845K0.24%US$343MSep 30, 2026

This page holds 50 of 2,202 holders. Open Shareholders

Funds

HolderSharesOf the companyValueAs of
Vanguard Total Stock Market Index Fund11.2M3.2%US$4.47BJun 30, 2026
Vanguard 500 Index Fund9.18M2.6%US$3.65BJun 30, 2026
Invesco QQQ Trust, Series 17.52M2.2%US$2.99BJun 30, 2026
iShares Core S&P 500 ETF4.87M1.4%US$1.94BJun 30, 2026
Fidelity 500 Index Fund4.54M1.3%US$1.93BMay 31, 2026
Vanguard Growth Index Fund3.85M1.1%US$1.53BJun 30, 2026
Growth Fund of America2.75M0.79%US$1.17BMay 31, 2026
Vanguard Health Care Fund2.73M0.79%US$963MJul 31, 2026
State Street(R) Health Care Select Sector SPDR(R) ETF2.5M0.72%US$995MJun 30, 2026
New Perspective Fund2.31M0.67%US$918MJun 30, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
Vanguard Institutional Index Fund1.92M0.55%US$765MJun 30, 2026
Growth Fund1.64M0.47%US$651MJun 30, 2026
Invesco NASDAQ 100 ETF1.51M0.44%US$641MMay 31, 2026
T. Rowe Price Blue Chip Growth Fund, Inc.1.44M0.42%US$574MJun 30, 2026
iShares Russell 1000 Growth ETF1.35M0.39%US$535MJun 30, 2026
T. Rowe Price Growth Stock Fund, Inc.1.25M0.36%US$498MJun 30, 2026
iShares U.S. Medical Devices ETF1.15M0.33%US$456MJun 30, 2026
Vanguard U.S. Growth Fund1.12M0.32%US$477MMay 31, 2026
Vanguard Health Care Index Fund1.06M0.31%US$452MMay 31, 2026
Capital Group Growth ETF963K0.28%US$409MMay 31, 2026
College Retirement Equities Fund - Growth Account918K0.26%US$365MJun 30, 2026
Harbor Capital Appreciation Fund872K0.25%US$308MJul 31, 2026
State Street(R) SPDR(R) Portfolio S&P 500(R) ETF844K0.24%US$336MJun 30, 2026
T. Rowe Price Large-Cap Growth Fund840K0.24%US$334MJun 30, 2026
Schwab S&P 500 Index Fund790K0.23%US$279MJul 31, 2026
Schwab U.S. Large-Cap Growth ETF758K0.22%US$322MMay 31, 2026
iShares S&P 500 Growth ETF748K0.22%US$297MJun 30, 2026
AB Large Cap Growth Fund Inc715K0.21%US$284MJun 30, 2026
Invesco S&P 500 Quality ETF674K0.19%US$238MJul 31, 2026
Fidelity Total Market Index Fund671K0.19%US$285MMay 31, 2026
Ultra Fund623K0.18%US$220MJul 31, 2026
JPMorgan Nasdaq Equity Premium Income ETF622K0.18%US$247MJun 30, 2026
JPMorgan Equity Premium Income ETF609K0.18%US$242MJun 30, 2026
College Retirement Equities Fund - Total Global Stock Account590K0.17%US$235MJun 30, 2026
Vanguard Russell 1000 Growth Index Fund583K0.17%US$248MMay 31, 2026
T. Rowe Price Health Sciences Fund, Inc.563K0.16%US$224MJun 30, 2026
Fidelity Series Total Market Index Fund542K0.16%US$230MMay 31, 2026
Global X Robotics & Artificial Intelligence ETF542K0.16%US$230MMay 31, 2026
State Street(R) SPDR(R) Portfolio S&P 500(R) Growth ETF529K0.15%US$210MJun 30, 2026
Vanguard Mega Cap Growth Index Fund525K0.15%US$209MJun 30, 2026
Select Medical Technology and Devices Portfolio523K0.15%US$222MMay 31, 2026
Fidelity Growth Company Fund484K0.14%US$206MMay 31, 2026
Bridge Builder Large Cap Growth Fund468K0.14%US$186MJun 30, 2026
Fidelity Large Cap Growth Index Fund464K0.13%US$164MJul 31, 2026
iShares Core S&P Total U.S. Stock Market ETF456K0.13%US$181MJun 30, 2026
Franklin Growth Fund455K0.13%US$181MJun 30, 2026
ClearBridge Large Cap Growth Fund454K0.13%US$193MMay 29, 2026
Invesco S&P 500 Equal Weight ETF452K0.13%US$160MJul 31, 2026
Loomis Sayles Growth Fund434K0.13%US$173MJun 30, 2026
Vanguard Large-Cap Index Fund414K0.12%US$164MJun 30, 2026

This page holds 50 of 1,100 holders. Open Shareholders

Insider trades

TradeTradeSharesPriceValueDate
Brosius Mark
Officer: EVP & Chief Mfg and Supply Cha
Sale46USD 407.24US$18,733Nov 20, 2026
Brosius Mark
Officer: EVP & Chief Mfg and Supply Cha
Sale46USD 420.95US$19,364Nov 19, 2026
Brosius Mark
Officer: EVP & Chief Mfg and Supply Cha
Sale46USD 430.63US$19,809Nov 18, 2026
Brosius Mark
Officer: EVP & Chief Mfg and Supply Cha
Sale46USD 437.33US$20,117Nov 17, 2026
Brosius Mark
Officer: EVP & Chief Mfg and Supply Cha
Sale46USD 444.38US$20,441Nov 16, 2026
Loeb Gary
Officer: EVP & Chief Legal and Complian
Sale400USD 458.15US$183KNov 10, 2026
Barratt Craig H
Director
Sale1,150USD 460.00US$529KNov 4, 2026
Guthart Gary S
Director
Sale10,000USD 457.34US$4.57MNov 4, 2026
Widman Fredrik
Officer: VP Corporate Controller
Sale5,448USD 436.06US$2.38MOct 30, 2026
Brosius Mark
Officer: EVP & Chief Mfg and Supply Cha
Sale63USD 453.60US$28,577Oct 30, 2026
Show 50 trades
TradeTradeSharesPriceValueDate
Brosius Mark
Officer: EVP & Chief Mfg and Supply Cha
Sale61USD 447.85US$27,319Oct 29, 2026
Brosius Mark
Officer: EVP & Chief Mfg and Supply Cha
Sale61USD 441.60US$26,938Oct 28, 2026
Brosius Mark
Officer: EVP & Chief Mfg and Supply Cha
Sale61USD 451.63US$27,549Oct 27, 2026
Brosius Mark
Officer: EVP & Chief Mfg and Supply Cha
Sale61USD 451.75US$27,557Oct 26, 2026
Wadors Patricia L
Officer: SVP Chief Human Resources Offi
Sale1,078USD 443.80US$478KOct 23, 2026
Barratt Craig H
Director
Sale1,150USD 443.80US$510KOct 23, 2026
Guthart Gary S
Director
Sale20,095USD 451.61US$9.08MOct 23, 2026
Widman Fredrik
Officer: VP Corporate Controller
Sale4,047USD 453.21US$1.83MOct 23, 2026
Widman Fredrik
Officer: VP Corporate Controller
Sale546USD 374.44US$204KSep 15, 2026
Widman Fredrik
Officer: VP Corporate Controller
Sale543USD 374.44US$203KSep 15, 2026
Brosius Mark
Officer: EVP & Chief Mfg and Supply Cha
Sale25USD 365.79US$9,145Sep 11, 2026
Brosius Mark
Officer: EVP & Chief Mfg and Supply Cha
Sale23USD 347.66US$7,996Sep 10, 2026
Brosius Mark
Officer: EVP & Chief Mfg and Supply Cha
Sale23USD 350.20US$8,055Sep 9, 2026
Brosius Mark
Officer: EVP & Chief Mfg and Supply Cha
Sale46USD 361.23US$16,617Sep 8, 2026
Brosius Mark
Officer: EVP & Chief Mfg and Supply Cha
Sale77USD 375.57US$28,919Aug 21, 2026
Brosius Mark
Officer: EVP & Chief Mfg and Supply Cha
Sale77USD 396.37US$30,520Aug 20, 2026
Brosius Mark
Officer: EVP & Chief Mfg and Supply Cha
Sale77USD 394.26US$30,358Aug 19, 2026
Brosius Mark
Officer: EVP & Chief Mfg and Supply Cha
Sale77USD 394.00US$30,338Aug 18, 2026
Brosius Mark
Officer: EVP & Chief Mfg and Supply Cha
Sale77USD 390.67US$30,082Aug 17, 2026
Guthart Gary S
Director
Sale10,000USD 400.00US$4MAug 11, 2026
Ladd Amy L
Director
Sale72USD 393.10US$28,303Aug 11, 2026
Ladd Amy L
Director
Sale400USD 379.00US$152KAug 10, 2026
Loeb Gary
Officer: EVP & Chief Legal and Complian
Sale400USD 379.00US$152KAug 10, 2026
Brosius Mark
Officer: EVP & Chief Mfg and Supply Cha
Sale28USD 351.00US$9,828Jul 31, 2026
Brosius Mark
Officer: EVP & Chief Mfg and Supply Cha
Sale28USD 346.83US$9,711Jul 30, 2026
Brosius Mark
Officer: EVP & Chief Mfg and Supply Cha
Sale28USD 360.21US$10,086Jul 29, 2026
Brosius Mark
Officer: EVP & Chief Mfg and Supply Cha
Sale28USD 365.58US$10,236Jul 28, 2026
Brosius Mark
Officer: EVP & Chief Mfg and Supply Cha
Sale28USD 344.00US$9,632Jul 27, 2026
Brosius Mark
Officer: EVP & Chief Mfg and Supply Cha
Sale25USD 414.13US$10,353Jun 12, 2026
Brosius Mark
Officer: EVP & Chief Mfg and Supply Cha
Sale23USD 412.16US$9,480Jun 11, 2026
Loeb Gary
Officer: EVP & Chief Legal and Complian
Sale400USD 424.14US$170KJun 10, 2026
Brosius Mark
Officer: EVP & Chief Mfg and Supply Cha
Sale23USD 424.14US$9,755Jun 10, 2026
Brosius Mark
Officer: EVP & Chief Mfg and Supply Cha
Sale23USD 421.13US$9,686Jun 9, 2026
Brosius Mark
Officer: EVP & Chief Mfg and Supply Cha
Sale23USD 420.12US$9,663Jun 8, 2026
Jeddi Iman
Officer: SVP & GM da Vinci Platforms &
Sale5,625USD 420.55US$2.37MJun 1, 2026
Brosius Mark
Officer: EVP & Chief Mfg and Supply Cha
Sale18USD 439.80US$7,916May 22, 2026
Brosius Mark
Officer: EVP & Chief Mfg and Supply Cha
Sale18USD 446.04US$8,029May 21, 2026
Brosius Mark
Officer: EVP & Chief Mfg and Supply Cha
Sale18USD 440.38US$7,927May 20, 2026
Brosius Mark
Officer: EVP & Chief Mfg and Supply Cha
Sale18USD 440.70US$7,933May 19, 2026
Brosius Mark
Officer: EVP & Chief Mfg and Supply Cha
Sale18USD 422.47US$7,604May 18, 2026

This page holds 50 of 53 trades. Open Shareholders

Big stakes

StakeStakeSharesDateFiling
Vanguard Capital Management LLC7.49%26.6MMar 31, 2026Schedule 13G

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
D. Keith Grossman
Other companies: Alcon AG (Board Member · Since at least May 16, 2026); MiniMed Group, Inc. (Director · Since at least Mar 6, 2026); Outset Medical, Inc. (Lead Independent Director · Since at least Sep 14, 2020); Nevro Corp (Director · Mar 19, 2019 – Apr 3, 2025 · Past); Zeltiq Aesthetics Inc (Director · Oct 24, 2013 – Apr 28, 2017 · Past); Conceptus Inc (President & CEO · Dec 13, 2011 – Jun 5, 2013 · Past); Kyphon Inc (Director · Apr 24, 2007 – Nov 2, 2007 · Past)
Director · May 19, 2006 – Apr 23, 2010 · Past
Keith R. Leonard
Other companies: Arcutis Biotherapeutics, Inc. (Director · Since at least Sep 2, 2021); Unity Biotechnology Inc (Director · May 2, 2018 – Jun 21, 2024 · Past); Kythera Biopharmaceuticals Inc (President & CEO, Director · Jan 29, 2012 – Oct 1, 2015 · Past); Affymax Inc (Director · Dec 6, 2007 – Jun 13, 2012 · Past); Aryx Therapeutics Inc (Director · Nov 7, 2007 – Apr 30, 2010 · Past)
Chairman, Unity Biotechnology, Inc · Since at least Jan 28, 2016
Lewis Chew
Other companies: Arista Networks, Inc. (Board Member · Since at least Jul 19, 2021); Cadence Design Systems, Inc. (Director · Since at least Mar 15, 2020); Dolby Laboratories (EVP & Chief Financial Officer · Jun 17, 2013 – Aug 17, 2021 · Past); PG&E Corporation (Director · Jun 11, 2013 – May 22, 2018 · Past)
Director · Since at least Apr 25, 2024
Marshall Mohr
Other companies: Veeva Systems Inc. (Director · Since at least Jan 21, 2022); Pacific Biosciences of California, Inc. (Director · Since at least Jan 18, 2012); Plantronics Inc (Director · Jul 27, 2010 – Aug 29, 2022 · Past); Atheros Communications Inc (Director · May 24, 2010 – May 24, 2011 · Past)
Director · Apr 30, 2010 – Nov 5, 2026 · Past
Myriam Curet
Other companies: Mobia Medical, Inc. (Board Member · Since at least Jul 30, 2026); Inspire Medical Systems, Inc. (Director · Since at least Dec 21, 2023); Stereotaxis, Inc. (Director · Since at least Jul 22, 2021); Nektar Therapeutics (Director · Dec 12, 2019 – Sep 18, 2023 · Past)
EVP & Chief Medical Officer · Since at least Dec 31, 2018
Don R Kania
Other companies: NanoString Technologies Inc (Director · Oct 30, 2019 – Jun 16, 2022 · Past); American Science & Engineering Inc (Director · Sep 9, 2016 – Sep 9, 2016 · Past); FEI Company (See Remarks, Director · May 17, 2016 – Sep 19, 2016 · Past)
Director · Jul 31, 2018 – Apr 25, 2024 · Past
Jamie Samath
Other companies: KLA Corporation (Director · Since at least Apr 30, 2025); Atmel Corp (ATML) (VP & Corporate Controller · Dec 16, 2011 – Feb 15, 2013 · Past); National Semiconductor Corp (VP, Corporate Controller · Nov 16, 2010 – Sep 23, 2011 · Past)
EVP & CFO & Enterprise Technol · Since at least May 7, 2013
Patricia L Wadors
Other companies: Procore Technologies, Inc. (Chief Talent Officer · May 19, 2021 – Apr 1, 2022 · Past); Accolade, Inc. (Director · Jul 1, 2020 – Apr 8, 2025 · Past); ServiceNow, Inc. (Chief Talent Officer · May 7, 2019 – Aug 17, 2020 · Past)
SVP Chief Human Resources Offi · Since at least Jan 29, 2026
Robert W. Duggan
Other companies: Summit Therapeutics Inc. (Co-CEO & Chairman of the Board · Since at least Sep 18, 2020); Pulse Biosciences, Inc (Director · Since at least Nov 2, 2017); Pharmacyclics Inc (Chairman and CEO, Director · Sep 17, 2007 – May 26, 2015 · Past)
Director · Feb 15, 2006 – May 18, 2011 · Past
Amal M. Johnson
Other companies: Essex Property Trust, Inc. (Director · Since at least May 11, 2021); CalAmp Corp (Director · May 13, 2021 – Jul 28, 2021 · Past)
Director · Since at least Apr 22, 2021
All 42 people
PersonSeat
Craig H. Barratt
Other companies: Astera Labs, Inc. (Director · Since at least Jun 4, 2026); Intel Corporation (Director · Since at least Mar 3, 2026)
Director · Since at least May 15, 2025
Gary S. Guthart
Other companies: Illumina, Inc. (Director · Dec 1, 2017 – May 21, 2025 · Past); Affymetrix Inc (Director · Mar 31, 2016 – Mar 31, 2016 · Past)
Executive Chair of the Board of Directors · Since at least Aug 1, 2016
Jami Nachtsheim
Other companies: Cerus Corporation (Chair · Since at least Jun 1, 2022); Telesis Bio, Inc. (Director · Jul 6, 2023 – Jul 6, 2023 · Past)
Director · Since at least Apr 22, 2022
Sreelakshmi Kolli
Other companies: Zimmer Biomet Holdings, Inc. (Director · Since at least Feb 18, 2021); Align Technology, Inc. (SVP & Mng Dir Info Tech · Nov 7, 2016 – Feb 20, 2020 · Past)
Executive Vice President, Chief Product and Digital Officer · Since at least Oct 27, 2023
Aaron Martin
Other companies: Humana Inc. (President, Medicare Advantage · Since at least Jan 26, 2026)
Director (from Jan 1, 2027) · Since at least Nov 2, 2026
Amy L Ladd
Other companies: Allakos Inc (Director · Jul 21, 2022 – May 15, 2025 · Past)
Director · Since at least Aug 1, 2019
Benjamin B Gong
Other companies: Pacific Biosciences of California, Inc. (Interim CFO and PAO · Aug 8, 2020 – Aug 8, 2020 · Past)
Vice President, Finance · Feb 7, 2006 – Mar 17, 2006 · Past
Gary Loeb
Other companies: Sangamo Therapeutics, Inc. (EVP, General Counsel & Sec. · Feb 25, 2021 – Mar 23, 2021 · Past)
EVP & Chief Legal and Complian · Since at least Sep 27, 2022
Mark J Rubash
Other companies: iRhythm Holdings, Inc. (Director · Since at least Jun 18, 2021)
Director · Apr 22, 2021 – Apr 25, 2025 · Past
Monica P. Reed
Other companies: Isleworth Healthcare Acquisition Corp (Director · Sep 8, 2021 – Sep 8, 2021 · Past)
President and CEO of UChicago Medicine Advent Health · Since at least Apr 22, 2021
William J Mercer
Other companies: Zoll Medical Corp (Director · May 30, 2006 – Jun 2, 2006 · Past)
Director · May 19, 2006 – Jun 2, 2006 · Past
Alan J LevyDirector · Apr 22, 2010 – Apr 25, 2024 · Past
Augusto V CastelloSVP Product Ops · Apr 21, 2011 – Feb 15, 2013 · Past
Brian Edward MillerEVP & Chief Digital Officer · Since at least Nov 10, 2025
Catherine MohrIntuitive Foundation President · Since at least Jan 27, 2025
Colin MoralesGM & SVP Secondary Mkt Equip & · Apr 21, 2011 – Feb 7, 2017 · Past
Dave RosaPresident · Since at least Jul 13, 2026
David J RosaChief Executive Officer (CEO), Director · Since at least Apr 21, 2011
Eric H HalvorsonDirector · Mar 14, 2016 – Apr 25, 2016 · Past
Fredrik WidmanVP Corporate Controller · Since at least Feb 10, 2024
George Stalk JrDirector · Oct 19, 2007 – Apr 20, 2017 · Past
Henry L CharltonEVP & Chief Commercial and Mkt · Since at least Jan 1, 2022
Iman JeddiSVP & GM da Vinci Platforms & · Since at least Jan 29, 2026
Joseph C BeeryDirector · Since at least Apr 23, 2020
Mark BrosiusEVP & Chief Mfg and Supply Cha · Since at least Feb 1, 2024
Mark J MeltzerSVP General Counsel & CCO · Jul 27, 2015 – Jun 7, 2018 · Past
Michele DiMartinoSee Remarks · Jan 25, 2023 – Feb 28, 2023 · Past
Reiter Kara AndersenSr VP General Counsel & CCO · Aug 29, 2022 – Aug 29, 2022 · Past
Richard Michael EpsteinSr. Vice President, Marketing · Feb 5, 2007 – Feb 15, 2007 · Past
Robert DeSantisEVP & Chief Strategy & Corp Op · Apr 1, 2020 – Apr 25, 2025 · Past
Salvatore BrognaEVP & Chief Operating Officer · Apr 21, 2011 – Dec 2, 2019 · Past
Thorax. PublishedCEO MESSAGE · Mar 17, 2026 – Nov 5, 2026 · Past

Open People

Log in to ask 6ix AI your own questions about Intuitive Surgical, Inc.